AstraZeneca has resumed the U.S. trial of its experimental COVID-19 vaccine after approval by regulators, and Johnson & Johnson is preparing to resume its trial early next week, the companies said on Friday.
Fred Katayama reports.
Daily Covid-19 Minute: Astrazeneca’s Vaccine Trial Has Been On Pause For 6 Weeks, Here’s What We Know
CBS 62 Detroit
Some good news in our race for a COVID-19 vaccine. Both Johnson & Johnson and Astrazeneca have announced they’re resuming phase 3..
